REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,632 | -48.8% | 45,042 | +13.1% | 0.00% | -100.0% |
| Q2 2023 | $1,008,401 | -45.6% | 39,842 | -30.7% | 0.00% | 0.0% |
| Q1 2023 | $1,852,655 | -36.6% | 57,518 | -63.7% | 0.00% | -50.0% |
| Q4 2022 | $2,922,569 | +234.8% | 158,319 | +389.6% | 0.00% | +100.0% |
| Q3 2022 | $873,000 | +54.2% | 32,337 | -21.0% | 0.00% | – |
| Q2 2022 | $566,000 | -36.5% | 40,953 | -10.5% | 0.00% | – |
| Q1 2022 | $892,000 | +7.9% | 45,762 | -9.7% | 0.00% | – |
| Q4 2021 | $827,000 | -38.0% | 50,660 | +5.8% | 0.00% | -100.0% |
| Q3 2021 | $1,334,000 | -28.2% | 47,896 | -23.6% | 0.00% | 0.0% |
| Q2 2021 | $1,858,000 | -52.3% | 62,687 | -55.0% | 0.00% | -50.0% |
| Q1 2021 | $3,897,000 | +173.7% | 139,453 | +177.4% | 0.00% | +100.0% |
| Q4 2020 | $1,424,000 | +50.1% | 50,275 | +33.2% | 0.00% | 0.0% |
| Q3 2020 | $949,000 | -71.1% | 37,758 | -71.9% | 0.00% | -50.0% |
| Q2 2020 | $3,285,000 | +26.2% | 134,567 | -23.5% | 0.00% | 0.0% |
| Q1 2020 | $2,602,000 | +3.0% | 175,862 | +12.9% | 0.00% | 0.0% |
| Q4 2019 | $2,526,000 | +525.2% | 155,712 | +397.9% | 0.00% | – |
| Q3 2019 | $404,000 | -93.8% | 31,274 | -93.8% | 0.00% | -100.0% |
| Q2 2019 | $6,555,000 | -11.6% | 505,536 | +7.4% | 0.00% | 0.0% |
| Q1 2019 | $7,417,000 | +11.1% | 470,747 | +41.9% | 0.00% | -20.0% |
| Q4 2018 | $6,678,000 | -40.7% | 331,820 | -26.8% | 0.01% | +66.7% |
| Q3 2018 | $11,261,000 | -29.1% | 453,190 | -21.6% | 0.00% | -40.0% |
| Q2 2018 | $15,874,000 | +207.3% | 578,314 | +244.8% | 0.01% | +150.0% |
| Q1 2018 | $5,165,000 | +12.5% | 167,739 | +30.5% | 0.00% | -33.3% |
| Q4 2017 | $4,592,000 | +45.6% | 128,488 | +12.2% | 0.00% | +50.0% |
| Q3 2017 | $3,153,000 | +2.0% | 114,476 | -2.3% | 0.00% | 0.0% |
| Q2 2017 | $3,090,000 | +800.9% | 117,140 | +608.0% | 0.00% | – |
| Q1 2017 | $343,000 | -30.6% | 16,545 | -30.9% | 0.00% | – |
| Q4 2016 | $494,000 | +57.8% | 23,957 | +23.5% | 0.00% | – |
| Q3 2016 | $313,000 | +4.3% | 19,406 | -12.5% | 0.00% | – |
| Q2 2016 | $300,000 | +39.5% | 22,184 | +79.0% | 0.00% | – |
| Q1 2016 | $215,000 | +13.2% | 12,391 | +120.9% | 0.00% | – |
| Q4 2015 | $190,000 | -72.5% | 5,609 | -75.9% | 0.00% | -100.0% |
| Q3 2015 | $692,000 | -72.1% | 23,316 | -69.9% | 0.00% | -50.0% |
| Q2 2015 | $2,479,000 | +201.2% | 77,526 | +95.0% | 0.00% | +100.0% |
| Q1 2015 | $823,000 | +558.4% | 39,767 | +436.4% | 0.00% | – |
| Q4 2014 | $125,000 | -38.4% | 7,413 | -29.6% | 0.00% | – |
| Q3 2014 | $203,000 | -56.2% | 10,532 | -23.0% | 0.00% | – |
| Q2 2014 | $464,000 | +743.6% | 13,679 | +681.7% | 0.00% | – |
| Q1 2014 | $55,000 | – | 1,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |